drugset / Trial / NCT06575933

A Study of Calderasib (MK-1084) With Midazolam and Digoxin in Healthy Participants (MK-1084-009)

NCT06575933

Phase 1 Completed 28 enrolled Merck Sharp & Dohme LLC
Non-randomizedSequentialOpen-labelTreatment

Summary

The goal of the study is to see what happens to levels of midazolam and digoxin in a person's body over time (a pharmacokinetic or PK study). Researchers will compare what happens to midazolam and digoxin in the body when it is given with and without another medicine called calderasib. Researchers are testing if digoxin and midazolam levels in the body are different when digoxin and midazolam are given with or without calderasib.

Timeline

Start
2024-09-03
Primary completion
2024-10-28
Completion
2024-10-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Calderasib Unknown Oral
Subject Digoxin Other / unclassified Oral
Subject Midazolam Small molecule Oral